UK Gambling Bonus Site Secures Exclusive Deal with European Bookmaker

The British based gambling bonus site Low Risk Winner have managed to secure an exclusive deal for its visitors, with popular European Bookmaker, Titanbet.

2012-01-11

January 11, 2012 (Press-News.org) Low Risk Winner, is a well known and trusted online gambling bonus site, created in July of 2010. It's aim has been to list all the best free bets, casino promotions, bingo offers and poker and games offers.

The site recently secured an exclusive bonus for its visitors with Titan Bet a popular online European bookmaker. Under normal circumstances when registering directly with Titan, users would receive a GBP25 promotion. However, when registering via Low Risk Winner, they can expect a GBP35 bonus instead.

Ryan Sheader, owner of Low Risk Winner had this to say, "We approached Titan back in October with a view to trying an improved deal for a short period, thankfully we saw some mutual benefit in the deal and some great results, and as a result it is now to stay in place for the foreseeable future. This benefits everybody, the site and the bookmaker reap the reward, plus it's something extra for our visitors too."

In addition to securing exclusive bonuses, the site is currently under going a overhaul, aimed at a new look and feel, and making the site easier to navigate around.

Ryan Sheader, commented, "We did a new design at the end of summer 2011, however since then we have reviewed trends and stats and we are always looking at ways of making things easier for our visitors, and improving the overall experience. The new overhaul is to be rolled out at the end of January 2012."

Low Risk winner was created by two web masters in July of 2010 on a small budget, and has quickly grown to attract tens of thousands of visitors a month and lists promotions from leading UK & European bookmakers and gaming sites. The site also has a keen presence in the world of social media, with their own Twitter feed.

About Lowriskwinner.com

Low Risk Winner is an impartial gambling bonus site, operated by a team of UK-based webmasters. Lowriskwinner.com was started in July 2010, intended to list the best bookmaker, casino and games offers.

Website: http://www.lowriskwinner.com

ELSE PRESS RELEASES FROM THIS DATE:

Penn researchers find treatment for diabetes and depression improves both

2012-01-11

(PHILADELPHIA) – Patients simultaneously treated for both Type 2 diabetes and depression improve medication compliance and significantly improve blood sugar and depression levels compared to patients receiving usual care, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Of patients receiving integrated care combined with a brief period of intervention to assist with adherence to prescribed medication regimens, more than 60 percent had improved blood sugar test results and 58 percent had reduced depression symptoms, ...

WHOI scientists contribute to comprehensive picture of the fate of oil from Deepwater Horizon spill

2012-01-11

A new study provides the composite picture of the environmental distribution of oil and gas from the 2010 Deepwater Horizon spill in the Gulf of Mexico. It amasses a vast collection of available atmospheric, surface and subsurface chemical data to assemble a "mass balance" of how much oil and gas was released, where it went and the chemical makeup of the compounds that remained in the air, on the surface, and in the deep water. The study, "Chemical data quantify Deepwater Horizon hydrocarbon flow rate and environmental distribution," is published online in the journal ...

Protein changes identified in early-onset Alzheimer's

2012-01-11

With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease. For researchers, however, such knowledge is a window into Alzheimer's disease's evolution. Understanding the biological changes that occur during the clinically "silent" stage — the years before symptoms appear — provides clues about the causes of the disease and may offer potential targets for drugs that will stop it from progressing. In a new study, researchers at UCLA ...

Metal oxide simulations could help green technology

2012-01-11

University of California, Davis, researchers have proposed a radical new way of thinking about the chemical reactions between water and metal oxides, the most common minerals on Earth. Their work appears in the current issue of the journal Nature Materials. The new paradigm could lead to a better understanding of corrosion and how toxic minerals leach from rocks and soil. It could also help in the development of "green" technology: new types of batteries, for example, or catalysts for splitting water to produce hydrogen fuel. "This is a global change in how people should ...

Researchers identify molecular 'culprit' in rise of planetary oxygen

2012-01-11

CHAMPAIGN, Ill. — A turning point in the history of life occurred 2 to 3 billion years ago with the unprecedented appearance and dramatic rise of molecular oxygen. Now researchers report they have identified an enzyme that was the first – or among the first – to generate molecular oxygen on Earth. The new findings, reported in the journal Structure, build on more than a dozen previous studies that aim to track the molecular evolution of life by looking for evidence of that history in present-day protein structures. These studies, led by University of Illinois crop sciences ...

Ganetespib showed activity in KRAS-mutant NSCLC as monotherapy and in combinations

2012-01-11

SAN DIEGO — The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active when combined with traditional lung cancer treatments and other investigational targeted therapies, according to preclinical study data. David A. Proia, Ph.D., and Jaime Acquaviva, Ph.D., scientists at Synta Pharmaceuticals Corp., presented the data at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy ...

Precancer markers identified in airway epithelium cells of healthy smokers

2012-01-11

SAN DIEGO -- Smoking may be associated with the development of molecular features of cancer in the large airway epithelium. In the small airway epithelium, molecular cancerization is associated with development of chronic obstructive pulmonary disease, according to recent data. "We are striving to find the earliest molecular changes that are induced by environmental stressors — in this case, smoking," said Renat Shaykhiev, M.D., Ph.D., assistant professor of genetic medicine at Weill Cornell Medical College, who presented the findings at the AACR-IASLC Joint Conference ...

Preventing mother to child transmission of HIV in Zimbabwe

2012-01-11

Preventing mother to child transmission of HIV in Zimbabwe In this week's PLoS Medicine, Andrea Ciaranello of Massachusetts General Hospital, Boston, USA and colleagues find, using a simulation model, that implementation of the latest WHO PMTCT (prevention of mother to child transmission of HIV) guidelines must take place in conjunction with improving access to PMTCT programs, increasing retention of women in care, and supporting adherence to drugs, in order to eliminate pediatric HIV in Zimbabwe. The authors say: "Although PMTCT uptake in low- and middle-income countries ...

Limited use of compulsory licensing of pharmaceuticals to protect public health

2012-01-11

Limited use of compulsory licensing of pharmaceuticals to protect public health Reed Beall and Randall Kuhn of the University of Denver, USA describe in this week's PLoS Medicine their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995. Specifically, the authors investigated the impact of the 2001 Doha Declaration on trends in compulsory licensing of pharmaceuticals. They highlight the need for further systematic evaluation of global health agreements. ###Funding: No direct funding was received ...

Long-term consequences of venous thrombosis

2012-01-11

Long-term consequences of venous thrombosis Linda Flinterman of Leiden University, the Netherlands and colleagues report in this week's PLoS Medicine on the long-term mortality rate for individuals who have experienced a first venous thrombosis or pulmonary embolism. They describe an ongoing elevated risk of death for individuals who had experienced a venous thrombosis or pulmonary embolism as compared to controls, for up to eight years after the event. The authors say: "To our knowledge, this has been the first study to calculate mortality rates compared with the general ...